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Inpatient hospital performance is associated 
with post-discharge sepsis mortality
Nicholas M. Mohr1,2* , Alexis M. Zebrowski3 , David F. Gaieski3 , David G. Buckler3  and Brendan G. Carr4
Abstract 
Background: Post-discharge deaths are common in patients hospitalized for sepsis, but the drivers of post-discharge 
deaths are unclear. The objective of this study was to test the hypothesis that hospitals with high risk-adjusted inpa-
tient sepsis mortality also have high post-discharge mortality, readmissions, and discharge to nursing homes.
Methods: Retrospective cohort study of age-qualifying Medicare beneficiaries with sepsis hospitalization between 
January 2013 and December 2014. Hospital survivors were followed for 180-days post-discharge, and mortality, read-
missions, and new admission to skilled nursing facility were measured. Inpatient hospital-specific sepsis risk-adjusted 
mortality ratio (observed: expected) was the primary exposure.
Results: A total of 830,721 patients in the cohort were hospitalized for sepsis, with inpatient mortality of 20% and 
90-day mortality of 48%. Higher hospital-specific sepsis risk-adjusted mortality was associated with increased 90-day 
post-discharge mortality (aOR 1.03 per each 0.1 increase in hospital inpatient O:E ratio, 95% CI 1.03–1.04). Higher inpa-
tient risk adjusted mortality was also associated with increased probability of being discharged to a nursing facility 
(aOR 1.03, 95% CI 1.02–1.03) and 90-day readmissions (aOR 1.03, 95% CI 1.02–1.03).
Conclusions: Hospitals with the highest risk-adjusted sepsis inpatient mortality also have higher post-discharge 
mortality and increased readmissions, suggesting that post-discharge complications are a modifiable risk that may be 
affected during inpatient care. Future work will seek to elucidate inpatient and healthcare practices that can reduce 
sepsis post-discharge complications.
Keywords: Sepsis, Quality of health care, Patient discharge, Patient readmission
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Background
Sepsis is a life-threatening condition that affects 1.7 mil-
lion Americans annually, with an in-hospital mortality of 
16% [1]. Costing over $60 billion each year, sepsis is the 
most expensive acute medical condition for which Medi-
care reimburses hospitals [2]. Early treatment has been 
shown to improve survival to hospital discharge [1, 3, 4], 
but sepsis case-fatality continues to vary significantly by 
hospital (41% for highest-mortality decile of hospitals vs. 
29% for lowest-mortality decile, p < 0.001) [5].
The burden of sepsis continues beyond hospital dis-
charge. Many sepsis survivors have persistent neurocog-
nitive deficits, neuromuscular weakness, symptoms of 
depression and post-traumatic stress disorder, and poor 
quality of life [6–10]. Readmissions after discharge are 
common (21% within 30 days) [11], and sepsis survivors 
have increased post-discharge mortality [12–14]. Post-
discharge deaths have been associated with premorbid 
health status and hospital factors [15, 16], but it is unclear 
whether these factors are modifiable, and whether hospi-
tal care can alter the post-discharge course.
The objective of this study was to determine the 
relationship between quality of hospital care (meas-
ured by hospital-specific inpatient adjusted sep-
sis survival) and post-discharge outcomes, including 
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mortality, readmissions, and skilled nursing facility 
discharge (Fig.  1). We postulate that hospitals that pro-
vide higher quality care have improved sepsis risk-
adjusted inpatient mortality and that this quality leads to 
improved post-discharge mortality in those who survive 
hospitalization. This analysis differs from prior work, in 
that we are evaluating a primary exposure of hospital 
performance (a more direct measure of hospital quality) 
rather than administrative or epidemiologic factors than 
may be related with quality indirectly, and our outcome 
includes only those who survive hospitalization [15–18]. 
Such a relationship would suggest that the impact of 
inpatient sepsis therapies may extend beyond hospital 
discharge, and that early treatment elements may change 
long-term immunity, organ function, and debility.
Methods
Study design, setting, and participants
This analysis was a retrospective cohort study of age-
qualifying Medicare beneficiaries with an emergency 
department (ED)-based hospitalization in a U.S. hospital 
for sepsis or septic shock between January 1, 2013 and 
December 31, 2014. Hospital encounters were identified 
using the Outpatient and Medicare Provider Analysis 
and Review (MedPAR) research identifiable files from 
the Centers for Medicare and Medicaid Services (CMS) 
administrative claims data, while patient demographic 
information and dates of death were obtained from the 
Medicare Beneficiary Summary File and Vital Status 
records. All cases were followed for 6 months after hos-
pital admission, with deaths from any cause captured 
through June 30, 2015 for the last-enrolling patients, 
and readmissions for any cause censored on December 
31, 2014 due to the years of Outpatient and MedPAR 
data available. In-hospital mortality was estimated using 
data from January 1, 2013 through December 31, 2014, 
and these mortality estimates were used for calculating 
observed-to-expected (O:E) mortality ratios for inclusion 
in subsequent explanatory models. Only hospitals with at 
least 200 cases during the 2-year period were included in 
the analysis to allow for more stable O:E ratio estimates. 
This study was approved by the local institutional review 
board (IRB) and is reported using the STrengthening 
the Reporting of OBservational studies in Epidemiology 
(STROBE) statement [20].
Definitions
Severe sepsis or septic shock was defined according to 
International Classification of Diseases, 9th edition, 
Clinical Modification (ICD-9-CM) diagnosis codes for 
septicemia with an additional diagnosis for organ dys-
function, as previously reported [21–23]. Rural residence 
was defined based on the county of residence, and was 
classified according to the 2013 Rural–Urban Contin-
uum Codes (RUCC) published by the U.S. Department 
of Agriculture [24]. Comorbidities were defined using the 
Elixhauser method, which identifies a set of 30 comor-
bid conditions from administrative data associated with 
increased mortality, length-of-stay, and charges [25]. 
Index hospital was the first hospital where a patient was 
seen for a given sepsis episode, while final hospital was 
the last hospital where a patient was seen (to account for 
patients transferred between hospitals for their care).
Exposures
Hospital‑specific mortality
The primary exposure was hospital-specific sepsis mor-
tality. Hospital-specific sepsis mortality was reported as 
an O:E mortality ratio based strictly on in-hospital mor-
tality for the final hospital in which a patient was treated, 
calculated for the study period 2013–2014. A multivari-
able logistic regression model was constructed with an 
outcome of in-hospital mortality and a priori-defined 
patient-level predictors, including age, race, sex, comor-
bidities, infection source, organ dysfunction, skilled nurs-
ing facility residence prior to admission, community 
Fig. 1 Proposed causal diagram for the hypothesized relationship between hospital-specific observed:expected (O:E) mortality ratio and 
post-discharge mortality. Shaded boxes indicate parameters that are measurable (non-shaded boxes are unmeasured). In our primary analysis, 
we are using inpatient O:E mortality as a surrogate approximation of hospital quality. The purpose of this analysis is to understand to what degree 
post-discharge mortality may be modifiable based on hospital-level care
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factors (percent Black, percent Hispanic, percent with 
high school degree or higher, percent below poverty line), 
ICU services in hospital, and teaching hospital. All vari-
ables were selected based on theory and the proposed 
relationship with exposures and outcomes, and the same 
adjustment variables were used for all models [5, 17, 26]. 
All continuous variables were modeled in categories, 
and interactions were tested. The predicted probability 
of mortality was generated for each case in the data set, 
then the sum of observed in-hospital mortality and pre-
dicted in-hospital mortality for each facility was calcu-
lated. The ratio of the observed mortality to the predicted 
mortality was the O:E ratio and was the primary predic-
tor in this analysis.
Primary and secondary outcomes
Primary outcome
The primary outcome was 90-day post-discharge mortal-
ity, measured from the date of hospital discharge among 
patients who survived their initial sepsis hospitalization. 
The primary analysis used a hierarchical logistic regres-
sion model clustered on the final hospital with the pri-
mary exposure of hospital-specific O:E mortality ratio 
and other potential patient and system-oriented con-
founders. Interactions were tested and all continuous 
variables were coded into categorical groups. Covariates 
for the model were selected based on prior data and pos-
sible confounders in patient-level, facility-level, and com-
munity-level variables.
Secondary analyses
Secondary analytic models were developed to measure 
mortality at 30  days, 60  days, and 180  days post-dis-
charge. A sensitivity analysis was performed using the 
hospital O:E ratio for the index hospital, rather than the 
final hospital, to determine if assigning ownership to the 
first hospital changed the association with post-discharge 
outcomes. Multivariable models were built similarly to 
measure the association between hospital-specific pre-
dictors on hospital discharge to skilled nursing facility 
(only among cases that did not reside in a skilled nursing 
facility at the time of index admission) and readmission 
within the first 90-days after discharge.
Sensitivity analysis
Survival models
An alternative approach was planned a priori to function 
as a sensitivity analysis (if the impact of hospital mortality 
on post-discharge mortality appeared preserved across 
time, supporting the proportional hazards assumption): a 
Cox proportional hazards model was developed with the 
same set of covariates and an outcome of time-to-death, 
among patients who survived the initial hospitalization. 
A second proportional hazards model was built for time-
to-readmission among hospital survivors.
Unobserved confounder
An “E-value” was calculated to determine the minimum 
strength of association required with both the predictor 
and the outcome, for an unobserved confounder to ren-
der the coefficient of our primary exposure null. In this 
way, we estimated how significant an unobserved vari-
able would have to be for our results to be attributable 
to confounding bias alone. To interpret this value, the 
reader might conclude that a confounding variable not 
included in the model would have to have an odds ratio 
of at least this value for our findings to be a result of con-
founding alone.
Analysis
For all multivariable models, continuous predictor vari-
ables were categorized to avoid the linearity assumption, 
interactions were tested for significance, and variables 
were screened for multicollinearity. All analyses are done 
using complete case analysis, and goodness of fit was 
assessed using area under the curve (AUC) of the final 
model. All statistical tests were considered significant for 
p < 0.05 using two-tailed tests, and all analysis was con-
ducted using Stata v.15.1. (StataCorp LLC, College Sta-
tion, Texas).
Results
A total of 830,720 age-qualifying Medicare beneficiar-
ies were hospitalized for sepsis between 2013 and 2014 
(Fig.  2). We excluded 123,807 admissions in 1922 low-
volume hospitals with fewer than 200 cases during the 
sample period. Most patients (68%) were hospitalized 
with either a respiratory or urinary infection source, 
14% had a co-existing malignancy, and 9% were admit-
ted from a skilled nursing facility (Table 1). Of all cases, 
1% were transferred between hospitals. In-hospital mor-
tality was 20% (n = 167,854), with 30-day, 90-day, and 
180-day cumulative mortality of 35% (n = 291,708), 43% 
(n  = 353,147), and 48% (n  = 398,914), respectfully. Of 
sepsis discharges, 37% (n = 247,045) were readmitted to 
a hospital within 180 days, with the median time to read-
mission approximately 32 days (IQR 12–73 days).
Association between in‑hospital mortality 
and post‑discharge mortality
The median index hospital O:E ratio was 1.00 (IQR 0.83–
1.17), with 1585 hospitals reporting at least 200 cases 
over the 2-year period. O:E ratios ranged from 0.29 to 
2.20 (IQR 0.83–1.17, Additional file 1: Fig. S1, Additional 
file 2: Table S1). In univariable modeling, increasing hos-
pital-specific O:E ratios were associated with increased 
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post-discharge mortality at 90-days (unadjusted OR 1.08 
for each 0.1 increase in hospital-specific O:E ratio, 95% 
CI 1.08–1.08). Controlling for potentially confounding 
patient-, facility-, and community-level covariates, the 
adjusted odds ratio showed a strong association between 
hospital O:E ratios and mortality (aOR 1.03 for each 0.1 
increase in hospital-specific O:E ratio, 95% CI 1.03–1.04). 
The magnitude of effect was unchanged for mortality 
from 30 to 180 days (Fig. 3, Additional file 3: Table S2).
Secondary outcomes
No differences were seen in the association between 
index hospital O:E and 90-day post-discharge mortality 
compared with the use of final hospital in the primary 
models (aOR 1.03, 1.03–1.04). Of the 610,874 patients 
that did not live in a nursing facility prior to their index 
sepsis admission and who survived to discharge, 25% 
(n = 153,378) were discharge to a SNF. Using a multivari-
able model similar to the primary model, patients from 
hospitals with the highest O:E ratios had an increased 
odds of being discharged to a skilled nursing facil-
ity (aOR 1.03 per 0.1 increase in O:E mortality ratio for 
final hospital, 95% CI 1.02–1.03). Similarly, patients 
from hospitals with the highest risk-adjusted mortality 
also had increased probability of 90-day readmissions 
(aOR 1.03 per 0.1 increase in O:E for final hospital, 95% 
CI 1.02–1.03). By 180-days after discharge, the adjusted 
odds of readmission had decreased to 1.02 per 0.1 
increase in O:E (95% CI 1.02–1.03).
Survival analysis
As a sensitivity analysis, a Cox proportional hazards 
model was used to measure the time to death, accounting 
for all the covariates from the logistic regression models 
and the hospital O:E ratio (Fig.  3). The hazard ratio for 
post-discharge mortality was higher in patients treated 
in a hospital with a higher O:E ratio (aHR 1.02 per 0.1 
increase in O:E for final hospital, 95% CI 1.02–1.03). A 
“dose–response” relationship was seen between hospital 
O:E and mortality with lower hazard for post-discharge 
mortality in the lower categories of hospital O:E (refer-
ence group < 0.75; 0.75–1.00: aHR 1.01, 95% CI 1.00–1.01; 
1.00–1.25: aHR 1.01, 95% CI 1.01–1.01; > 1.25: aHR 1.02, 
95% CI 1.01–1.02). A Cox proportional hazards model 
was also used to assess time to readmission. In adjusted 
models, higher hospital O:E ratios were associated with 
increased readmissions (aHR: 1.02 per 0.1 increase in O:E 
for index hospital, 95% CI 1.02–1.03). For hospitals with 
an O:E ratio > 1.25, median time to readmission within 
the first 180 days after discharge was 30 days (IQR 11–69) 
compared with 34  days in hospitals with an O:E < 0.75 
(IQR 13–76).
In our sensitivity analysis to measure the theoretical 
magnitude of an unobserved confounder (E-value), the 
magnitude of bias introduced by an unmeasured variable 
must have an odds of at least 2.05 (lower 95% CI 1.88). 
A moderately strong predictor of both hospital O:E and 
death at 90 days would be required to result in null find-
ings (similar in magnitude to premorbid cancer diagno-
sis or nursing home residence). It seems unlikely that an 
unobserved variable predicting mortality with a magni-
tude equal to nursing home residence exists.
Discussion
The relationship between sepsis and post-discharge 
mortality has been well established [12–14, 27], but 
whether post-discharge mortality has modifiable treat-
ment-related risks remained unclear. This question has 
been challenging to answer, since the specific biological 
mechanisms by which post-sepsis mortality is elevated 
have not been well elucidated. Mechanistic data suggest 
that sepsis survivors remain immune suppressed [28, 
29], have increased rates of atherosclerosis [13, 30], and 
that epigenetic regulation may play a role in modulating 
these effects [31]. The question that mechanistic studies 
have not answered, however, is whether improved inpa-
tient care can attenuate the impact on late post-discharge 
mortality. By analyzing variation between U.S. hospitals, 
our data suggests that it may.
Fig. 2 Flow diagram of study subjects. Non-index sepsis encounters 
include prior admissions, readmissions, transfers (at the receiving 
hospital), and skilled nursing facility admissions
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Table 1 Baseline characteristics of the study population
Characteristic Descriptive statistics
All cases (n = 830,720) Survived 
to discharge 
(n = 662,866)
n (%) n (%)
Patient characteristics
 Sex
  Male 393,852 (47.4) 314,824 (47.5)
  Female 436,868 (52.6) 348,042 (52.5)
 Race
  White 641,526 (77.2) 512,243 (77.3)
  Black 101,581 (12.2) 79,308 (12.0)
  Other 87,613 (10.6) 71,315 (10.8)
 Age
  65–74 years 274,021 (33.0) 225,032 (33.9)
  75–84 years 303,933 (36.6) 242,410 (36.6)
  85+ years 252,766 (30.4) 195,424 (29.5)
 Urbanicity of residence (by RUCC code)
  Urban (metro counties) 740,872 (89.2) 590,784 (89.1)
  Rural (nonmetro counties) 89,377 (10.8) 71,715 (10.8)
  Other/unknown 471 (0.1) 367 (0.1)
 Cancer diagnosis
  None 715,653 (86.2) 580,536 (87.6)
  Metastatic solid tumor 10,656 (1.3) 7,208 (1.1)
  Non-metastatic solid tumor 72,133 (8.7) 51,807 (7.8)
  Hematologic malignancy 32,278 (3.9) 23,315 (3.5)
 Infection source
  Urinary tract 338,046 (40.7) 288,389 (43.5)
  Pneumonia 225,647 (27.2) 171,908 (25.9)
  Abdominal 33,433 (4.0) 24,135 (3.6)
  Bloodstream 26,217 (3.2) 22,148 (3.3)
  Cellulitis 24,288 (2.9) 21,407 (3.2)
  Bone 17,909 (2.2) 15,247 (2.3)
  Surgical 10,960 (1.3) 9329 (1.4)
  Ear, nose, throat 1240 (0.2) 1130 (0.2)
  Meningitis 1051 (0.1) 832 (0.1)
  Gastrointestinal 794 (0.1) 755 (0.1)
  Other/unknown 151,135 (18.2) 107,586 (16.2)
 Organ dysfunction
  Renal 250,655 (30.2) 212,506 (32.1)
  Neurologic 227,220 (27.4) 177,610 (26.8)
  Metabolic 145,086 (17.5) 101,214 (15.3)
  Hematologic 73,996 (8.9) 61,618 (9.3)
  Cardiac 50,414 (6.1) 39,498 (6.0)
  Respiratory 41,985 (5.1) 35,072 (5.3)
  Hepatic 8396 (1.0) 5525 (0.8)
  Other/unknown 32,968 (4.0) 29,823 (4.5)
 Admission from skilled nursing facility
  No 759,098 (91.4) 618,575 (93.3)
  Yes 71,622 (8.6) 50,291 (7.6)
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Table 1 (continued)
Characteristic Descriptive statistics
All cases (n = 830,720) Survived 
to discharge 
(n = 662,866)
n (%) n (%)
Hospital characteristics
 ICU services available
  No 10,409 (1.3) 8,633 (1.3)
  Yes 736,934 (88.7) 588,136 (88.7)
  Not reported/unknown 83,377 (10.0) 66,097 (10.0)
 Council of teaching hospitals member
  No 675,249 (81.3) 541,556 (81.7)
  Yes 150,440 (18.1) 117,176 (17.7)
  Not reported/unknown 5031 (0.6) 4134 (0.6)
Community characteristics (zip code)
 Percent of population unemployed
  0–5% 95,725 (11.5) 77,264 (11.7)
  6–8% 260,369 (31.3) 208,787 (31.5)
  9–11% 230,791 (27.8) 184,317 (27.8)
  12–15% 155,421 (18.7) 123,043 (18.6)
  ≥ 16% 88,414 (10.6) 69,455 (10.5)
 Percent of population, black or African American
  0–1% 183,904 (22.1) 148,852 (22.5)
  2–3% 145,025 (17.5) 116,636 (17.6)
  4–5% 87,997 (10.6) 70,587 (10.6)
  6–10% 124,661 (15.0) 99,529 (15.0)
  11–20% 114,407 (13.8) 90,978 (13.7)
  21–40% 90,602 (10.9) 71,360 (10.8)
  ≥ 41% 84,124 (10.1) 64,924 (9.8)
 Percent of population, Hispanic
  0–1% 90,385 (10.9) 72,473 (10.9)
  2–3% 153,434 (18.5) 123,561 (18.6)
  4–5% 106,717 (12.9) 85,911 (13.0)
  6–10% 156,509 (18.8) 124,846 (18.8)
  11–20% 136,061 (16.4) 108,231 (16.3)
  21–40% 101,608 (12.2) 803,78 (12.1)
  ≥ 41% 86,006 (10.4) 67,466 (10.2)
 Percent of population, high school degree or higher
  0–20% 105,685 (12.7) 83,642 (12.6)
  21–25% 129,294 (15.6) 102,210 (15.4)
  26–28% 103,013 (12.4) 82,093 (12.4)
  29–33% 177,288 (21.3) 142,046 (21.4)
  34–38% 149,051 (17.9) 119,137 (18.0)
  39–45% 107,329 (12.9) 86,421 (13.0)
  ≥ 46% 59,060 (7.1) 47,317 (7.1)
 Percent of population, below poverty line
  0–7% 159,421 (19.2) 128,113 (19.3)
  8–10% 118,812 (14.3) 95,364 (14.4)
  11–15% 183,827 (22.1) 147,216 (22.2)
  16–18% 91,917 (11.1) 73,484 (11.1)
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Inpatient quality can be difficult to measure [32, 33], 
and the factors associated with sepsis quality are myriad 
[34, 35]. The Early Management Bundle for Severe Sep-
sis/Septic Shock (SEP-1) [19] reported by the Centers for 
Medicare and Medicaid Services is one parameter for 
ranking hospitals on adherence with a single bundle of 
very early care, but this measure is not a comprehensive 
measure of sepsis quality of care and the specific causal 
relationship between SEP-1 performance and outcomes 
has been questioned [36–40]. By using an inclusive meas-
ure of risk-adjusted inpatient sepsis mortality aggregated 
at the facility level, we have attempted to capture quality-
of-care by its outcome. This study design cannot identify 
which factors are associated with preventing late mortal-
ity or readmissions, but it provides evidence that care 
factors that affect inpatient outcomes may continue to 
influence patients after hospital discharge.
What factors might be responsible for the magnitude 
of the association? Factors associated with post-dis-
charge death could fall into one of four categories: early 
resuscitation interventions, sub-acute organ support 
and infection management, de-escalation of therapy, and 
post-discharge planning and care coordination. Early 
care interventions, such as timely antibiotics and hemo-
dynamic resuscitation could decrease organ failure and 
limit the degree of subclinical organ dysfunction persist-
ing at hospital discharge. Immunomodulatory effects of 
resuscitation may prevent both early organ failure and 
persistent immune dysfunction [43].
The overall elements of care that are performed after 
initial resuscitation, including antibiotic use and dis-
continuation, diuresis, early mobility, delirium manage-
ment, nutrition, and other factors may also contribute to 
sepsis outcomes [4, 44–46], but the specific manner in 
which these practices function as predictors and effect 
modifiers is not well described. Early mobility, timely 
extubation, and delirium prevention strategies are well-
described methods of decreasing mortality and disabil-
ity from critical illness, and thus are attractive targets to 
investigate in future studies [47–49]. Finally, discharge 
Table 1 (continued)
Characteristic Descriptive statistics
All cases (n = 830,720) Survived 
to discharge 
(n = 662,866)
n (%) n (%)
  19–25% 152,570 (18.4) 121,147 (18.3)
  ≥ 26% 124,173 (15.0) 97,542 (14.7)
Fig. 3 Cox proportional hazard model curves showing adjusted time-to mortality (a) and time-to-readmission (b) for patients who survive a sepsis 
hospitalization. Curves are stratified into cohorts defined by the quartile of observed:expected (O:E) in-hospital sepsis mortality aggregated at 
the level of the hospital. Survival analysis is adjusted for age, race, sex, comorbidities, infection source, organ dysfunction, skilled nursing facility 
residence prior to admission, community factors (percent Black, percent Hispanic, percent with high school degree or higher, percent below 
poverty line), ICU services in hospital, teaching hospital
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planning and care coordination may play a significant 
role in post-discharge follow-up, access to care, medica-
tion management, and the transition to community living 
[50]. Discharge planning, care coordination, and degree 
of pre-discharge medical recovery also may explain 
the relationship between inpatient O:E mortality, new 
skilled nursing discharges, and readmissions, but none of 
these elements were tested in our analysis. Gadre, et  al. 
recently reported readmissions after nearly 18% of sepsis 
discharges, and they were associated with more comor-
bidities, longer index hospital stays, and residence in 
skilled nursing facilities [51]. Although conclusive causal 
relationships have not been established, one might pre-
dict that (1) providing high-quality sepsis care that lim-
its deconditioning and chronic organ dysfunction, (2) 
scheduling discharge timing and managing chronic dis-
ease well, and (3) developing strong relationships with 
primary care providers, community organizations, and 
post-acute care providers to provide a seamless post-
acute care transition may effectively limit the need for 
both skilled nursing and readmissions.
This study has several limitations. First, our use of 
observational data limits our statistical models to vari-
ables commonly recorded in administrative data, allow-
ing for the possibility of unobserved confounders. These 
available data also led to our use of hospital O:E mortality 
as a surrogate for hospital quality—likely an incomplete 
surrogate with some potential for residual confounding 
and sensitive to differences in coding practices between 
hospitals. Second, we included only Medicare beneficiar-
ies in these data. While two-thirds of sepsis cases in the 
U.S. are Medicare beneficiaries, using these cases alone 
isolates a population over age 65 with reliable payment 
for healthcare services.
Conclusions
In conclusion, hospitals with the lowest risk-adjusted 
sepsis inpatient mortality also have reduced post-dis-
charge mortality. These observations suggest that some 
factors influencing in-hospital mortality also influence 
post-discharge outcomes, and some of these factors may 
be modifiable. Future work should focus on identifying 
factors associated with post-discharge outcomes and 
optimizing inpatient and transitional care to improve the 
likelihood of functional long-term recovery.
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